Avelo, a Schlieren-based start-up, has just closed its oversubscribed seed financing round of CHF 2.2 Mio. to accelerate the clinical validation of their breath collector in order to make a difference in the fight against Tuberculosis
Avelo, a Schlieren-based start-up, has just closed its oversubscribed seed financing round of CHF 2.2 Mio. to accelerate the clinical validation of their breath collector in order to make a difference in the fight against Tuberculosis